NEXGEL, Inc. (NXGL)

Market Cap	24.81M
Revenue (ttm)	6.73M
Net Income (ttm)	-3.53M
Shares Out	7.52M
EPS (ttm)	-0.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76,434
Open	3.270
Previous Close	3.260
Day's Range	3.250 - 3.420
52-Week Range	1.711 - 3.550
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About NXGL

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name. It is also developing NEXDrape, an incis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Dec 22, 2021
• Employees: 19
• Stock Exchange: NASDAQ
• Ticker Symbol: NXGL
• Website: https://nexgel.com

Financial Performance

In 2023, NEXGEL's revenue was $4.09 million, an increase of 99.66% compared to the previous year's $2.05 million. Losses were -$3.16 million, -33.48% less than in 2022.